Skip to main content
. 2017 Jan 12;7:40323. doi: 10.1038/srep40323

Table 1. Offline evaluation of integrated hybrid cryogel based bioreactor seeded with HepG2 cells.

  Bilirubin
AST
Ammonia
Albumin
Urea
UT T % change UT T % change UT T % change UT T % change UT T % change
P1 15.09 3.86 −74.42 341.2 105.9 −68.96 290.3 189.5 −34.72 2.38 3.59 +50.84 7.12 12.66 +77.81
P2 12.51 3.37 −73.06 201.6 105.3 −47.77 266.1 163.9 −38.41 1.68 3.36 +100 9.59 12.66 +32.01
P3 3.91 0.99 −74.68 68.95 58.34 −15.39 276.2 162.3 −41.24 2.01 3.13 +55.72 12.33 12.81 +3.89
P4 8.04 3.12 −61.19 208.6 85.3 −59.11 282.6 166.3 −41.15 2.22 3.74 +68.47 9.86 12.81 +29.9
P5 6.84 1.99 −70.91 118.5 107.4 −9.37 289.5 200.7 −30.67 1.76 3.31 +88.07 10.55 10.45 −0.95
P6 3.9 1.09 −72.05 150.3 82.2 −45.31 293.3 164.4 −43.95 1.75 3.61 +31.27 7.31 9.63 +31.74
P7 3.3 1.33 −59.7 178.6 102.3 −42.72 263.9 146.3 −44.56 2.04 3.42 +67.65 12.33 12.35 +0.162
P8 3.85 1.05 −72.72 111.4 80 −28.19 272.4 153.1 −43.8 1.94 3.16 +62.89 7.81 9.5 +21.64
P9 5.27 1.34 −74.57 106.1 84.2 −20.64 275.2 165.2 39.97 1.51 3.03 +20.72 7.31 9.62 +31.6
Avg −70.4 ± 5.8 −37.5 ± 20 −39.8 ± 4.6 +60.6 ± 25 +25.3 ± 24
Ref 0.3–1.2 mg/dL 10–40 IU/L 12–60 μg/dL 3.5–5.2 g/dL 15–40 mg/dL

UT: Untreated patient plasma; T: Treated patient plasma. Percent change in parameter post-treatment calculated as the difference between T and UT divided by UT multiplied by 100 (i.e ((T-UT)/UT)*100). Positive (negative) sign represents an increase (decrease). Average (Avg) is the mean ± SD (n = 9) value of percent increase or decrease obtained from 9 samples treated in the integrated bioreactor. Reference (Ref) is the normal human plasma values for the biochemical parameters in the table.